B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Diseases of glycosylation

REACTOME PATHWAY
Reactome: R-HSA-37818658 genes17 compounds

The Diseases of glycosylation pathway (Reactome ID: R-HSA-3781865) involves 8 genes and is affected by 17 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ADAMTS4ADAMTS5CTSAGALK1GALNT3LARGE1MPIMUC1

Compounds Affecting Diseases of glycosylation

#CompoundTargets HitStudies
1egcg300
2streptonigrin299
3piceatannol300
4caffeic acid300
5Rutin300
6Metergoline144
7Methyldopa297
8Oxytetracycline300
9Tolazamide169
10Hexachlorophene300
11Quercetin300
12Aurintricarboxylic Acid184
13Luteolin 5,7,3',4'-tetrahydroxy-flavone,150
14Apigenin 5,7,4'-trihydroxy-flavone,300
15Methylene Blue200
16Bortezomib300
17urolithin d2

About the Diseases of glycosylation Pathway

The Diseases of glycosylation pathway is catalogued in Reactome (ID: R-HSA-3781865) and involves 8 genes. In the BiohacksAI corpus, 17 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ADAMTS4, ADAMTS5, CTSA, GALK1, GALNT3.